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This study investigates the impact of reduced transmural conduction velocity (TCV) on output parameters of the human heart. In a
healthy heart, the TCV contributes to synchronization of the onset of contraction in individual layers of the left ventricle (LV).
However, it is unclear whether the clinically observed decrease of TCV contributes significantly to a reduction of LV
contractility. The applied three-dimensional finite element model of isovolumic contraction of the human LV incorporates
transmural gradients in electromechanical delay and myocyte shortening velocity and evaluates the impact of TCV reduction on
pressure rise (namely, ðdP/dtÞmax) and on isovolumic contraction duration (IVCD) in a healthy LV. The model outputs are
further exploited in the lumped “Windkessel” model of the human cardiovascular system (based on electrohydrodynamic
analogy of respective differential equations) to simulate the impact of changes of ðdP/dtÞmax and IVCD on chosen systemic
parameters (ejection fraction, LV power, cardiac output, and blood pressure). The simulations have shown that a 50% decrease
in TCV prolongs substantially the isovolumic contraction, decelerates slightly the LV pressure rise, increases the LV energy
consumption, and reduces the LV power. These negative effects increase progressively with further reduction of TCV. In
conclusion, these results suggest that the pumping efficacy of the human LV decreases with lower TCV due to a higher energy
consumption and lower LV power. Although the changes induced by the clinically relevant reduction of TCV are not critical for
a healthy heart, they may represent an important factor limiting the heart function under disease conditions.
1. Introduction
Cardiac conduction velocity (CV), the speed with which an
electrical impulse propagates through the cardiac tissue, is
one of the most important electrophysiological characteris-
tics of heart muscle. In comparison with normal hearts, the
myocardial CV was found to be significantly reduced in dis-
eased animal and human hearts [1–4]. The reduction of CV
was shown to increase the risk of reentrant activities that can
lead to cardiac arrhythmias (for review, see King et al. [5]).
In human cardiac muscle, the CV consists of two compo-
nents, the longitudinal (between 60 and 70 cm/s [4]) and the
transversal (TCV, around 50 cm/s [4]). The transmural
decrease of electromechanical delay (EMD) from endocar-
dium to epicardium (EMD gradient ~2.1ms/mm [6]) helps,
in combination with TCV, to synchronize the onset of con-
traction in individual layers of the left ventricle (LV) [6].
However, there are, to our best knowledge, no published
experimental results on the impact of TCV reduction on
the ventricle contractility. Thus, it is unclear whether the
clinically observed decrease of TCV and the corresponding
transmural desynchronization of LV contraction contributes
to a reduction of LV contractility or whether it rather repre-
sents a consequence of pathological changes at a cellular level
without any significant effect on the LV function.
An attempt to quantify the effect of CV reduction on
mechanical response of the mammalian heart and basic
hemodynamic parameters was undertaken recently by
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Yuniarti and Lim [7]. In their simulations using an inte-
grated electromechanical model of the LV, the CV correlated
with cardiac pumping efficacy. While a decrease of CV from
70 to 30 cm/s induced a relative reduction of ejection frac-
tion (EF) and stroke work by ~7 and 12%, respectively, the
ATP consumption increased by ~7%. However, the model
was formulated for canine heart and did not incorporate
transmural differences either in EMD or in myocyte short-
ening velocity (MSV) observed by Cordeiro et al. [8].
In the present study, our recently published three-
dimensional finite element (FE) model of isovolumic con-
traction (IVC) of the human LV [6] incorporating trans-
mural gradients in EMD and MSV was used to examine the
effect of changes in TCV on dynamics of LV pressure rise
dPV/dt and IVC duration (IVCD) in a healthy human heart.
In the second step, we used our lumped model of the human
cardiovascular system to simulate the impact of the observed
changes in ðdPV/dtÞmax and IVCD on cardiovascular hemo-
dynamics and arterial pressure.
2. Methods
2.1. Model of the Human Left Ventricle. The impact of
decrease in TCV on IVCD and ðdPV/dtÞmax was investigated
using a three-dimensional FE model of the human LV cre-
ated recently (in commercial FE software ANSYS®) to simu-
late the isovolumic phase of LV systole. The model is based
on simplified ellipsoidal geometry meshed with hexahedral
quadratic solid elements. Passive behaviour of myocardium
(considered as purely elastic) was described with a trans-
versely isotropic strain energy density function determining
the constitutive relation between stresses and (elastic) strains.
Active contraction of myocytes was modelled using special
reinforcing elements with unidirectional stiffness which were
created within the underlying solid mesh. Their active ten-
sion was generated using a simple approach based on ficti-
tious thermal strains. By gradually decreasing a fictitious
temperature of the reinforcing elements (with a certain coef-
ficient of thermal expansion), negative thermal strains are
developed and naturally counterbalanced by positive elastic
strains; consequently, tension in the fibre direction is gener-
ated. In order to reflect the LV fibre architecture, the orienta-
tion of these elements was changed gradually across the wall
between +60° and -60° (with respect to circumferential direc-
tion) on the endocardial and the epicardial surfaces, respec-
tively [9]. Blood inside the LV cavity was modelled as
incompressible liquid. In the control simulation, the electri-
cal activation of LV myocardium was modelled under the
assumption of simultaneous activation of the whole endocar-
dial surface and subsequent endocardium-to-epicardium
propagation at a constant TCV of 47 cm/s [1, 4]. Electrical
activation time for each element was calculated as a ratio of
the distance of the element from the endocardial surface
and of the TCV value (under control conditions). The same
calculation was applied with decreased TCV in the simula-
tions of pathological conditions. Transmurally heteroge-
neous values of EMD and MSV were prescribed in all
simulations following Cordeiro et al. [8]. As the contractile
elements generate tension, the intraventricular pressure rises
until the systemic diastolic blood pressure (80mmHg) is
reached. By decreasing the TCV (while keeping the other
parameters unchanged), different time-pressure curves were
calculated for various levels of myocardial conductivity.
ðdPV/dtÞmax and IVCD were evaluated from these curves
for each case. Besides the pressure data, wall stress in the
direction of fibres was assessed, as well as the total strain
energy accumulated in the LV walls in the end of the IVC
(SEIVC) which reflects its energetic demands. For further
details regarding the FE model and simulation conditions,
the reader is referred to our previous paper [6].
The basic exploration of the impact of decrease in TCV
on IVCD and ðdPV/dtÞmax was done by comparing the model
outputs in control conditions and under TCV reduced to
50% (as observed by Taggart et al. [4] in patients after 3
minutes of ischemia).
2.2. Model of the Cardiovascular System. To simulate the
impact of the observed changes in ðdPV/dtÞmax and IVCD
on cardiovascular hemodynamics and arterial pressure, we
reduced and modified our previously developed Windkessel
(WK) model [10] describing the interaction of the heart with
the vascular system. The reduced version of the WK model
incorporates only the functions of the LV and left atrium
(LA) that are necessary for the simulation of effects investi-
gated in this study. The electrical equivalent scheme of the
model is illustrated in Figure 1. In this model, the function
of atrioventricular and aortic valves is represented by the
marks of diodes (DAV, Da) with intrinsic resistances (RDAV,
RDa) and the resistance of vessels against blood flow by the
marks of a resistor (Ra, Rp, Rv). Distensibility of the individ-
ual types of vessels (their viscoelastic compliance [11]) is rep-
resented by the marks of a capacitor (Ca1, Ca2, Cv) in
combination with resistors (Ra1, Ra2), and the inertia of blood
is symbolised by the inductor (L). The volume of blood
pumped repeatedly by the LV into the arterial system creates
characteristic changes of arterial pressure known as pulse
waves. Propagation of these waves along arteries and the
pressure gradient between arterial and venous system under-
lay the blood circulation. The function of the LV is based on
two important mechanisms influencing the time course of
blood pressure development, the Frank–Starling mechanism,
and the law of Laplace. Thus, the model involves all key
events affecting systemic blood circulation and represents a
more elaborated system than those published previously
(see reviews by Zhou et al. [12] and Westerhof et al. [13]).
2.2.1. Implementation of the Frank–Starling Mechanism. The
Frank–Starling mechanism defines the relation between end-
diastolic volume (VVed) and strength of cardiac muscle con-
traction; it was implemented into the model by means of the
following 3rd and 2nd order polynomial equations:
PVed = aVV3Ved, ð1Þ
PVivmax = PVivmax,M − bV VVed − VVed,Mð Þ2, ð2Þ
where PVed and PVivmax, respectively, stand for end-diastolic
ventricular pressure and the isovolumic maximum
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ventricular pressure (that could be achieved during persisting
IVC at a given end-diastolic volume VVed), and PVivmax,M rep-
resents the peak value of PVivmax (275mmHg) achievable at
VVed of 200ml (VVed,M). The related points (VVed,M, PVed,M)
and (VVed,M, PVivmax,M) (see Figure 2) were then used to com-










2.2.2. Implementation of the Law of Laplace. LV is simplified in
this model to a spherical shape with inner radius r and wall
thickness h. Consistently with the law of Laplace, the internal
pressure PV induced by normal stress σV in the wall of the
model (formulated below) was computed as
PV = σVAV, ð4Þ









The approximation of the LV by a sphere allows us to
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As Vm is constant during the whole heart cycle (muscles
consist of 95% of incompressible water) and VV decreases
after the opening of the aortic valve, the increase of AV result-
ing from equation (10) contributes to the rise of PV during the
ejection phase.
2.2.3. Implementation of Muscle Contraction and Relaxation.
For the mathematical formulation of the muscle contraction
and relaxation during one cardiac cycle, we used the follow-
ing function in the model:




where constants kV1 and kV2 and exponents iV1 and iV2 con-
trol the contraction/relaxation rate and tVmax is the time from
the origin of the excitation (in the sinoatrial node) to the
maximal contraction of LV. The development of stress σV
in the ventricle wall during the cardiac cycle was described
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where KVc represents a coefficient of contractility (1 in con-
trol conditions) which reflects the level of neural activity









Figure 1: Electrical equivalent scheme of the model of left heart and systemic circulation. The individual symbols in the scheme stand for the
left atrium and ventricle (LA, LV); atrioventricular and aortic valves (DAV, Da); inertia of blood (L); resistance against the blood flow in aorta,
in peripheral vessels, and in the terminal part of the venous system (Ra, Rp, Rv); viscoelastic compliance of the initial segment of aortic arch
(Ca1, Ra1) and of the remaining aorta (Ca2, Ra2); and elastic compliance of the terminal part of the venous system (Cv). The symbols PA, PV,
Parc, Pa, and Pv stand for the pressures in the left atrium, left ventricle, aortic arch, aorta, and venous system.Qa represents blood flow in aorta.
The values of individual parameters are specified in Table 1.
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σV during the ejection along with the decrease of VV and,
hence, stretch of muscle fibres. This function was formulated
to ensure the physiological time course of PV [15] and values
of diastolic and systolic arterial pressures during a steady
cardiac cycle under control conditions [16]. Its mathemati-
cal form is







and numerical values of parameters Ke and ie are specified in
Table 1.
An analogical approach as used for the formulation of LV
function was applied to describe the function of LA. How-
ever, because at rest the contribution of LA to the perfor-
mance of normal left heart is small [17], the description of
LA was simplified. The relation between LA pressure (PA)
and volume (VA) during the LA filling was formulated by
means of 5th order polynomial equation:









The development of PA during the whole cardiac cycle
was then described by the equation:
PA = aAV5A + f Ac 7:5 − bA VA −VA,Mð Þ2
 	
, ð16Þ
where bA = 0:00075mmHg/ml2 and f Ac represent LA con-
traction defined by the term:
f Ac = exp − abs t − tAmaxð ÞkA½ iA
n o
: ð17Þ
Here, constant kA and exponent iA control the contrac-
tion/relaxation rate of LA and tAmax is the time from the ori-
gin of the excitation (in the sinoatrial node) to the maximal
contraction of LA.
The parameters of the WK model (see Table 1) were
recursively optimised by the least square method using nor-
malised differences between the model outputs and the
required values (see Table 2—standard) to make the model
capable to mimic the physiological properties of the human























Figure 2: Pressure-volume diagram showing the passive end-diastolic pressure-volume curve (PVed versus VVed) and isovolumic maxima
curve (PVivmax versus VVed) formulated in the WK model to reflect values in the human LV [14]. The points (VVed,M, PVed,M) and (VVed,M,
PVivmax,M) represent values at theoretically maximal diastolic filling.
Table 1: Parameters of the WK model.
RDAV 0.012mmHg·s/ml∗ KVc 1
RDa 0.025mmHg·s/ml∗ kV1 5.68722
Ra1 0.05mmHg·s/ml kV2 5.2270
Ra2 0.026mmHg·s/ml iV1 2.0224
Ra 0.0001mmHg·s/ml iV2 9.11538
Rp 1mmHg·s/ml tVmax 0.3568 s
Rv 0.01mmHg·s/ml Ke 1.355
Ca1 0.08ml/mmHg ie 0.35
Ca2 1.3ml/mmHg kA 24
Cv 70ml/mmHg iA 7
L 0.0003mmHg·s2/ml tAmax 0.12 s
∗Valid only for open state. Under closed state (when PV > PA or Parc > PV),
the corresponding resistance (RDAV or RDa) is set to 10
4 mmHg·s/ml.
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from 6 differential and two algebraic equations is presented
in the appendix. The model was implemented in the com-
putational system MATLAB14A-Simulink (MathWorks,
Inc.). The numerical computation of the system of differ-
ential equations was performed using solver ODE-45 (with
absolute and relative errors set to 10-4 and 5·10-6, respec-
tively). To obtain steady cycles under control conditions
or decreased TCV, the model was run for 60 s of equiva-
lent real time; prolongation of the simulation time to
120 s did not change the model output values by more
than 0.01%. The stability of the model was tested by run-
ning the model at parameters changed by 30 and 50%,
specifically those related to cardiac contractility (Kvc),
physical properties of the valves (RDAV ,RDa), and of the
vessels (Ra1, Ra2, Ra, Rp, Rv, Ca1, Ca2, Cv, L). In all the
cases, the model converged and steady cycles were achieved
within 60 s.
3. Results
3.1. Impact of Decreased Transmural Conduction Velocity
on the Function of the Left Ventricle during Isovolumic
Contraction. To explore the impact of decreased TCV on
function of left ventricle during IVC, we used our FE model
of LV and simulated the development of intraventricular
pressure and underlying changes in wall stress under control
conditions, and when TCV was slowed by 50% (see methods
for detailed explanation). The results illustrated in
Figure 3(a) show that such decrease in TCV would cause
an increase of IVCD from 60 to 71ms and a slight reduction
of ðdPV/dtÞmax from 1780 to 1750mmHg/s. For comparison,
Figure 3(a) includes also two clinically measured normal
pressure traces (digitized from literature [18, 19]) which
demonstrate a good agreement between our FE model and
clinical observations. Besides the changes in values of the
parameters derived from the pressure traces, an increased
wall stress was detected in the endocardial and midmyocar-
dial layers of the LV at the end of IVC (Figure 3(b)). This
elevation of wall stress was reflected by an increase of S
EIVC from 441 to 466mJ (by 6%) indicating higher energetic
demands of IVC when TCV was slowed.
3.2. Impact of Decreased Transmural Conduction Velocity on
Left Ventricular Performance and Blood Pressure. The analy-
sis described in the previous section indicates that 50%
reduction of TCV causes a significant prolongation of IVCD
by 18% and a small reduction of ðdPV/dtÞmax by 2%. To
incorporate this effect into the WK model, we increased the
tVmax to 0.3885 and reduced KVc to 0.982. Such change con-
sistently resulted in the increase of IVCD (from 60 to 71ms)
and reduction of ðdPV/dtÞmax from 1783 to 1750mmHg/s
during the first cycle. The consequences of these changes
on cardiovascular hemodynamics and arterial pressure in a
steady cycle (after 60 s of 1.2Hz stimulation) are illustrated
in Figure 4. The simulations reveal that these changes impli-
cate a delayed and weakened contraction (upper graph), with
consequences for time distribution and magnitude of LV and
arterial pressures (middle graph), and for LV power (WLV)
computed from the area of the loop in the PV – VV diagram
(bottom graph). The quantitative analysis of this effect sum-
marized in Table 2 shows a reduction of EF, cardiac output
(CO), and WLV by ~2, 2, and 4%, respectively, and the con-
sequent decrease of the systolic and diastolic arterial pres-
sures (Pa,s and Pa,d) by 2 and 1%, respectively.
To assess the instantaneous impact of TCV reduction on
IVCD, ðdPV/dtÞmax, and SEIVC in greater detail, we repeated
the simulations with the FE model using TCV values between
100 and 10%. The results presented in Figure 5 show that a
reduction of TCV from 100 to 50% caused a nearly linear
increase of IVCD and decrease of ðdPV/dtÞmax. However, fur-
ther reduction of TCV below 50% caused a highly nonlinear
change of both of these contractility indexes. On the other
hand, the strain energy exhibited approximately linear
dependence on TCV in the whole range of the explored
values. Adjusting the WK model for values of IVCD and
ðdPV/dtÞmax that were obtained by the FE model at TCV
reduced to 30, 20, and 10% of the control value resulted in
a reduction of WLV and CO, respectively, by ~7, 20, and
41% and by ~4, 10, and 23%. Consequently, the Pa,s and
Pa,d decreased, respectively, by ~4, 10, and 22% and by ~3,
9, and 20% giving values Pa,s/Pa,d of 120/78, 113/73, and
98/64.
To sum up, these simulations suggest that the isolated
impact of TCV on LV performance is rather small when
TCV is reduced from 100 to 50% of its control value but that
it increases progressively under further reduction of TCV.
4. Discussion
Cardiac CV is a parameter determining the velocity of depo-
larization wave propagation through the myocardium. As
the excitation is rapidly distributed to the whole inner endo-
cardial layer by the cardiac conduction system and extensive
Table 2: Parameters representing cardiovascular hemodynamics
and LV performance in a steady cycle obtained from literature
(Standard), from the model under control conditions (Control),
and at TCV decreased to 50% (50% TCV).
Standard Control 50% TCV
Pa,s 120mmHg 125mmHg 122mmHg
Pa,d 80mmHg 80mmHg 79mmHg
dPV/dtð Þmax 1780 mmHg/s 1783mmHg/s 1751mmHg/s
VV,ed 120ml 114ml 114ml
VV,es 40ml 36ml 37ml
IVCD 60ml 60ms 71ms
EPD 210ml 211ms 213ms
EF 67% 69% 67%
CO 5600ml/min 5653ml/min 5538ml/min
WLV 1.5W 1.51W 1.45W
Pa,s: systolic pressure in the aorta; Pa,d: diastolic pressure in the aorta; VV,ed:
end-diastolic volume in the LV; VV,es: end-systolic volume in the LV; EPD:
duration of ejection phase; EF: ejection fraction; CO: cardiac output; WLV:
power of the LV. The standard values of parameters were taken from [6, 21].
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net of Purkinje fibres in human LV [22], the critical factor
responsible for the propagation of excitation through the
ventricular wall is TCV. Although the CV and the related
TCV have been observed to decrease in diseased human
hearts [1, 2, 4], it is not clear how much this decrease con-
tributes to the reduction of LV contractility. To answer this
question, we used our previously published FE model of
human LV and performed simulations showing the effect
of slowed TCV on ðdPV/dtÞmax and IVCD. Subsequently,
the impact of the changes of ðdPV/dtÞmax and IVCD—in-
duced in the FE model by the lower TCV—on the cardiovas-
cular hemodynamics and the arterial pressure was simulated
using a modified version of our lumped model of systemic
cardiovascular circuit.
4.1. Causes of Slowed Transmural Conduction Velocity in the
Cardiac Left Ventricle. In principle, the TCV is determined
by the rate of local depolarisation of cardiomyocytes and by
the rate of excitation propagation between them (in transver-
sal direction). These two determinants of TCV are closely
related to the amplitude of fast Na+ current (INa) in ventric-
ular myocytes, to their membrane capacitance (Cm), and to
their transversal resistance (Rt) controlled by cardiac gap
junctions (mainly formed by connexin43, Cx43) which real-
ize the cell-to-cell couplings. Changes of these three factors
underlying slowed TCV have been observed in a variety of
pathophysiological conditions. Firstly, INa is reduced by the
impaired function of Na+ channels that arise clinically during
heart failure, ischemia, tachycardia, or as a consequence of
treatment with class I antiarrhythmic drugs [5]. Such reduc-
tion may be also induced by Na+ channel mutations that
occur in Lenègre disease, Brugada syndrome, sick sinus syn-
drome, and atrial fibrillation [5, 23]. Secondly, Cm is usually
substantially increased under ventricular hypertrophy which
reflects the thickening and elongation of ventricular myo-
cytes. This change is known to be induced by hypertension
[24], valvular disease (mitral valve regurgitation or aortic
valve stenosis [25, 26]), congenital heart disease (such as pat-
ent ductus arteriosus or coarctation of the aorta [27, 28]), and
a primary disease of the myocardium which directly cause
hypertrophy (hypertrophic cardiomyopathy [29]). Finally,
Rt may increase due to gap junction decoupling following
ischemia, fibrotic change of the heart tissue (e.g., after myo-
cardial infarction) [30], or as a result of mutations of genes
encoding gap junction protein connexions [31]. Besides,
downregulation and dephosphorylation of Cx43 have been
reported to contribute to an increase of Rt and thus to a
slower propagation of excitation through the LV wall in fail-
ing hearts [1, 3].
4.2. Effect of Slowed Transmural Conduction Velocity on the
Function of the Cardiovascular System. The simulations on
the FE model suggest that the isolated reduction of TCV
results in a prolongation of IVCD and decrease of
ðdPV/dtÞmax. To explore the effect of these two changes on
the LV performance and cardiovascular hemodynamic, the
modified form of our WK model [10] was used (see
Figure 1). An analysis of the WK model parameters showed
that the above effect observed in the FE model could be rep-
licated most effectively by an increase of tVmax which controls
the time of activation of LV contraction (equation (11)), and
by a decrease of coefficient KVc which determines the strength




















(dP/dt)max = 1780 mmHg/s
IVC time = 60 ms
(dP/dt)max = 1750 mmHg/s
IVC time = 71 ms
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Figure 3: (a) Effect of a 50% decrease of TCV on pressure rise in the LV during IVC. Pressure development obtained in the control simulation
is compared with two normal pressure traces (in grey) digitized from literature [18, 19]. (b) Effect of a 50% decrease of TCV on distribution of
stresses (in the direction of myofibres) across the LV wall (from endocardium—0% to epicardium—100%) in the end of IVC.
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Figure 4: Simulation of function of systemic cardiovascular circuit during a steady cycle at resting heart rate (72 beats/min, stimulation
interval 0.8333 s) in control conditions (black lines) and after incorporation of changes (increase of tVmax and decrease of KVc) resulting in
prolongation of IVCD and reduction of ðdPV/dtÞmax (grey lines); these changes were obtained by means of the FE model after decrease of
TCV to 50%. The traces in the upper graph represent the time courses of LV contraction, and ΔtVmax represents a delay of the maximum
contraction under the reduced TCV against control conditions. The middle graph shows the time course of development of PV (solid), PA
(dotted), and Pa (dashed) under both explored conditions; the small black vertical lines mark the beginning and end of IVC. The bottom
graph shows the corresponding PV – VV diagrams with their loop area representing the LV stroke work; for comparison with PV –VV
diagram measured in normal human LV see Figure 12.2 in [20].
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of cardiac muscle contraction (equation (12)). Implementation
of the effects of 50% reduction of TCV (i.e., ~18% increase of
IVCD and ~2% decrease of ðdPV/dtÞmax, see Figure 3(a)) in
the WK model affected its behaviour only moderately: EF
and CO decreased by 2%, WLV by 4%, and the effect on Pa,s
and Pa,d was small. However, it is important to emphasize that
in fact the evaluated impacts on both SEIVC andWLV sum up.
While the FEmodel shows an increase of SEIVC by 6%, theWK
model shows a decrease ofWLV by 4% under these conditions.
It means that during contraction, the LV consumes more
energy to develop wall stress but its contractile power declines.
Consequently, the resulting efficiency of the heart contraction
decreases approximately by 10%; clearly, this is only true when
the increase of energy consumption during the ejection phase
(not included in the FE model) is proportional to that during
IVC. In any case, such a decrease of efficiency of heart contrac-
tion may be significant for the efficiency of blood supply, espe-
cially in combination with some other pathologies impairing
the LV function. The simulations also predict that the above
described effects of lower TCV would increase substantially if
TCV dropped under 50%. The reason of this increase was a
continuous rise of SEIVC (Figure 5) and a progressive reduc-
tion ofWLV (see Section 3.2). Hence, the reduction of TCV to
30, 20, and 10% of control value resulted in a decrease of con-
traction efficacy of LV by 16, 29, and nearly 50%, respectively.
The described effects are fully consistent with the recent
work by Yuniarti and Lim [7] presenting simulations based
on an electromechanical model of canine heart coupled
with a lumped model of circulatory system. Their results
also showed an increase in the electrical activation time
(equivalent to IVCD) and in end-systolic volume with
reduction of the CV, while systolic pressure, stroke volume,
and stroke work decreased rather moderately. All these ten-
dencies correspond to those depicted in Figures 3 and 4 and
suggest that clinically relevant reduction of TCV does not
affect critically the function of the cardiovascular system
under normal conditions.
4.3. Clinical Implications. The reduction of CV is usually mir-
rored by the increased duration of QRS complex in ECG
records. QRS prolongation (>120ms) is a significant predic-
tor of LV systolic dysfunction in patients with heart failure
[32] and is known to be accompanied by higher propensity
to arrhythmias [33, 34]. On the other hand, because QRS
can be affected by disorders of cardiac electrical conduction
system (e.g., by left bundle branch block), the prolonged
QRS does not necessarily mean that intraventricular CV is
slowed down. To unambiguously differentiate between the
causes of QRS prolongation, new diagnostic methods allow-
ing to monitor LV activation pattern [35, 36] would be very














































Figure 5: Impact of TCV reduction on three indexes characterizing left ventricle contractility and energetic demands of IVC in the model:
(a) IVCD, (b) ðdPV/dtÞmax, and (c) strain energy. 100% TCV represents a normal human LV.
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helpful in clinical practice. The possibility to directly identify
a reduced TCV and knowledge of its relation to cardiac con-
traction efficiency might be an impulse for the development
of new andmore effective therapies targeted to normalization
of intraventricular spread of excitation in patients with car-
diac disease. Besides reperfusion of heart tissue, this could
involve also a potentiation or upregulation of some mem-
brane transporters (e.g., sodium channels or gap junction
channels) which could lead to normalization of cellular excit-
ability and intercellular electrical conductance. A future more
elaborated version of the model incorporating cell-to-cell
electrical interaction could be also helpful for mapping of
arrhythmogenic substrate in the myocardium in patients
with a hereditary cardiac disease such as Brugada syndrome.
4.4. Limitations of the Model. The FE model used in this
study is based on an idealized (ellipsoidal) geometry of the
LV. It also employs a simplified electrical activation pattern
taking into consideration the propagation of the electrical
signal only in the transmural direction; consequently, the
entire endocardium is activated simultaneously. Neverthe-
less, assuming that propagation of depolarisation around
the LV cavity is much faster than in the transmural direction
[37], this represents a reasonable approximation. Also, the
passive mechanical behaviour of human myocardium is
orthotropic [38] rather than transversely isotropic as applied
in our model; thus, further improvement could be achieved
by employing an orthotropic hyperelastic model, e.g., that
proposed by Holzapfel and Ogden [39]. Finally, besides a
dramatic transmural variation, moderate changes in fibre
direction have been observed also in circumferential direc-
tion and between base and apex [9]. These minor variations
are not included in our model. We believe the mentioned
limitations may change the results quantitatively but without
a significant impact on the drawn conclusions.
5. Conclusions
On the basis of combination of two computational models,
FE model of left ventricle and WK model of cardiovascular
hemodynamics, the presented study suggests that the pump-
ing efficacy of human heart decreases with lower TCV due to
a higher energy consumption and lower LV power. Although
the observed changes induced by the clinically relevant
reduction of TCV are not critical for healthy heart, they
may represent an important factor limiting cardiac function
when combined with other pathologies impairing contractil-
ity of the LV. As numerous heart pathologies are associated
with TCV reduction, further exploration of the impact of
TCV on the contractility of diseased hearts is needed.
Appendix
Differential Equations of the WK Model
Pressure induced by the elastic component of aortic arch
dPCa1
dt





































Pa − Pvð Þ/Rp − Pv − PAð Þ/Rv
Cv
: ðA:5Þ
Blood flow through the aorta
dQa
dt
= Parc − Pa − RaQað Þ
L
: ðA:6Þ
Volume of the left atrium
dVA
dt






Volume of the left ventricle
dVV
dt
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